Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and Keratoacanthoma

erlotinib hydrochloride has been researched along with Keratoacanthoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agulnik, M; Guitart, J; Lacouture, ME; Reid, DC1
Bulj, TK; Cetner, AS; Krunic, AL; Villano, JL1

Other Studies

2 other study(ies) available for erlotinib hydrochloride and Keratoacanthoma

ArticleYear
Treatment of multiple keratoacanthomas with erlotinib.
    International journal of clinical oncology, 2010, Volume: 15, Issue:4

    Topics: Aged, 80 and over; Antineoplastic Agents; ErbB Receptors; Erlotinib Hydrochloride; Humans; Immunohistochemistry; Keratoacanthoma; Male; Neoplasms, Multiple Primary; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; Skin Neoplasms; Treatment Outcome

2010
Refractory aggressive keratoacanthoma centrifugum marginatum of the scalp controlled with the epidermal growth factor receptor inhibitor erlotinib.
    The British journal of dermatology, 2010, Volume: 163, Issue:3

    Topics: Aged; ErbB Receptors; Erlotinib Hydrochloride; Female; Head and Neck Neoplasms; Humans; Keratoacanthoma; Protein Kinase Inhibitors; Quinazolines; Scalp; Skin Neoplasms; Treatment Outcome

2010